Pharmafile.com’s weekly COVID-19 news round-up
July 22, 2020Research and Development COVID-19, coronavirus
The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …
Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder
July 21, 2020Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure
Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …
India begins human trials of its first homegrown coronavirus vaccine
July 21, 2020Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus
India has begun human trials of its first internally developed vaccine for COVID-19. The Indian Council of Medical Research have …
AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data
July 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus
Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait
July 21, 2020Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus
Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …
North Korea says it’s developing its own coronavirus vaccine
July 21, 2020Manufacturing and Production COVID-19, North Korea, coronavirus
North Korea has announced it is developing a vaccine against COVID-19. The announcement was made on 18 July by the …
Is Pharma doing enough on sustainability?
July 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability
Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India
July 20, 2020Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir
Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …
Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show
July 20, 2020Research and Development, Sales and Marketing COVID-19, Synairgen
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
Israeli doctor tests positive for coronavirus 3 months after recovering
July 20, 2020Sales and Marketing COVID-19, coronavirus
An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …
England’s test and trace system breaks GDPR data law, according to privacy group
July 20, 2020Sales and Marketing Contact tracing, GDPR, coronavirus, covid19
England’s test and trace programme broke General Data Protection Regulation (GDPR) data law according to the Open Rights Group (ORG). …
UK secures early access to 90 million doses of coronavirus vaccines
July 20, 2020Sales and Marketing COVID-19, coronaviurs, vaccines
The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.
Innate Pharma announces new Executive Vice President and Chief Medical Officer
July 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment
Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …
AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks
July 17, 2020Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track
AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …
WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption
July 17, 2020Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines
The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …
FDA grants fast review for Bayer and MSD’s heart failure drug vericiguat
July 17, 2020Medical Communications Bayer, FDA, MSD
The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat. This was based on …
Hydroxychloroquine proves ineffective against COVID-19 in newest trial
July 17, 2020Medical Communications COVID-19, coronavirus, hydroxychloroquine
The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients. A recent study was published in the …
Top Ten most popular articles on Pharmafile.com this week
July 17, 2020Medical Communications top 10
The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it is the first …
COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest
July 16, 2020Medical Communications, Research and Development digital, healthcare, pharma
The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …
AstraZeneca’s Brilinta reduces the rate of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack
July 16, 2020Business Services AZ, AstraZeneca, drug trials
AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
